Member Info for Hopester

Cancer will directly affect over one in four people and indirectly affect almost everyone over their lifetime.
Has it not occurred to the gloateurs and fantasists that come out of the woodwork when the sp drops that many people invested here are more interested in the technology and potential impact on treatment than turning a quick buck. These investors are unlikely to be panicked by the transparent efforts of the merchants of doom who seize on any sp glitch to spread tales of woe.
Everyone likes to make money, and no doubt there are many trading this share, but LTHs on here are likely to be seeing the bigger picture, sitting back and smiling.
All IMHO

I seem to remember an RNS a couple of years back outlining a procedure to simplify the examination of a solid biopsy. The normal procedure would be FFPE sample preparation which would then be sliced up and mounted on a series of microscope slides which would be examined to detect tumour cells.
The paper described a process - dissolution I think they termed it but probably a blitz in a kitchen blender!
The resultant sample slurry was then run through a Parsortix instrument and any tumour cells in the sample were captured in the cassette. Only one slide to examine. It seemed that the process was quite reliable.

Not enough movement to stir the thinking investors or enough of a drop to trigger the gloateurs and fantasists.
Enjoy the weekend all LTH.

You're very quiet today Deepestblue.
Is everything OK?

It does make you wonder what's going on here Drums.
Another RNS demonstrating a valuable application in the monitoring of SCLC and yet the price still slides.
That said, I'm putting every bean I can lay my hands on into here at these fire sale prices.
Good luck to those with sufficient nerve not to be rattled by current happenings.
All IMHO

Oilbagger
If there was an early placing like you suggest, could you, or any other contributor, predict what the terms would be?
Is there a standardised formula for these events?
I hope this isn't a dumb question, I just want to be sure I have an adequate wedge in place to enable me to take up my allocation. Exciting times. GLA.

Left feeling like he'd been booted up the a#se and pi##ing blood for a week is how my friend described his prostate biopsy.
If this procedure (which must cost well over £1000 to perform) can be replaced by a Parsortix test then patients, hospital boards and shareholders are all going to be winners. All IMHO

Hmmm!
Wholeheartedly agree - we ain't seen nothing yet.
In the midst of our euphoria, I think we should all spare a thought for GoingLarge. Hard lines GL - some you win....

Ninja
Your Thu 18:18 post.
I'm getting that translated into Latin and it's going on my coat of arms! Brilliant.

OHG
It's not just the final findings that will be of importance, it's what discoveries might be made along the way.
CTC capture might replace solid biopsy ( the thought of which procedure makes my eyes water) and early findings might translate into improved treatment and monitoring.
3-5 years is a fairly short timescale IMO.
Novel drugs for cancer treatment is a huge focus in the industry, but all roads lead back to Angle for monitoring and assessment IMHO.

Do we have an informed time scale for the relocation of a system? If the Daresbury system was to be moved to Harley St, would it simply be a matter of transporting and reconnecting the modules, pipework and cabling or would we be looking at many months of alignment, tuning and conditioning?

It's really good to know that things are working out so well for you GL.
You're some trader. Respect.

Excellent article PJT - well spotted.
I think Abbott will have to put their hands a lot deeper into their pockets though.
This will skyrocket on FDA approval and will steadily climb further in the next year or two as applications develop and revenue rises. I don't think too many LTHs would be interested in being barged aside for a measly £10 per share.
This is a totally game changing technology with potential to save thousands of lives and billions of dollars.
All IMHO

GL
Buy and sell at the prices that best fit your strategy - but we really don't need to know.
I wish you the best of luck.

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-covid-19-diagnostic-test-using-breath-samples

Maybe this approval will free up the logjam! GLA

Like I said, if we had failed to gain FDA approval, we would have heard by now.
If the application was rejected then I think at least it would galvanise people into more fully exploring what Parsortix could be used for and actively pursuing those applications.
There have been so many game changing discoveries made in the last few years using Parsortix and I think we are approaching a real crisis as cancer sufferers face delays in diagnosis and treatment due to Covid disruption.
Let's hope this equipment can bring prospects of a better outcome to all those struggling with this terrible scourge.
GLA and all IMHO

Many of the reported breakthroughs and findings refer to treatment monitoring and I fail to see how lack of FDA would prevent it being used for that purpose.
This morning's RNS has been a one off use of Parsortix to isolate CTCs and establish a drug target to reduce CTC shedding. Probably not a lot of future revenue from that particular research facility although their findings will be highly important in the battle to reduce the chance of metastasis.
The main revenues will be from labs carrying out routine monitoring of patients undergoing treatment.
My personal feeling is that if FDA were planning to reject the application, we'd have heard by now. All IMHO

I would have thought that FDA approval would have taken things a long way down the track for MHRA approval. Hopefully the UK authorities will take a more pragmatic approach.

Does it every time Dave. Kicks up and then trickles back.
With each earth shaking RNS the kick seems to be smaller and the trickle back time becomes less.

You're correct BOJO,
Each time we have a game changing study result (and they've been coming in steadily for years as you point out) the share price kicks up by 5-10% and then trickles back over the next week or so, almost to where it started. Is it just lack of FDA that's keeping the lid on all these potential applications?